Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
This hypersensitivity for GH further pushes up the already elevated IGF-1 production, while on top of that IGF-1 actions are also increased because of the hyperinsulinemia-induced reduction in IGFBP-1 [35]
These remedies either decrease melanin production or dispose of layers of the pores and skin where melanin is focused
Both require medical oversight and differ in dosing schedules and approved indications
Key protective strategies include: Pre-treatment ophthalmologic evaluation : Establish baseline retinal status before initiating GLP-1 therapy, particularly in patients with diabetes duration exceeding 10 years or poor prior glycemic control Individualized medication titration : Consider a more gradual dose escalation approach to avoid precipitous drops in blood glucose for patients with advanced diabetic retinopathy, in coordination with ophthalmology care Appropriate monitoring : Discuss with your healthcare provider whether more frequent eye examinations are needed based on your individual risk factors and baseline retinal status Prompt reporting of visual symptoms : Contact your healthcare provider immediately if you experience sudden vision loss, new or dense floaters, flashing lights, a "curtain" over your vision, eye pain with vision changes, or any sudden vision disturbance Patients without pre-existing diabetic retinopathy can generally follow standard eye examination schedules and do not require additional ophthalmologic monitoring solely due to GLP-1 use
was supported by NIH/NHGRI R01HG011138 and R35HG010718
